Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-27 1:32 pm Sale | 2026-03-13 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 0 0.000% | -673,605 (Position Closed) | Filing History |
| 2026-01-30 2:45 pm Purchase | 2025-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 673,605 5.020% | 116,648 (+20.94%) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 854,579 6.700% | 174,543 (+25.67%) | Filing History |
| 2025-12-31 4:10 pm Purchase | 2025-12-29 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Point72 Asset Management, L.P. | 1,235,058 9.200% | 1,235,058 (New Position) | Filing History |
| 2025-10-31 11:31 am Purchase | 2025-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | VANGUARD GROUP INC | 556,957 6.350% | 556,957 (New Position) | Filing History |
| 2025-10-17 6:41 pm Purchase | 2025-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 680,036 7.800% | 259,588 (+61.74%) | Filing History |
| 2025-07-17 8:12 pm Purchase | 2025-06-30 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 420,448 5.700% | 420,431 (+2473123.53%) | Filing History |
| 2025-02-14 5:05 pm Sale | 2024-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -4,322 (Position Closed) | Filing History |
| 2025-01-03 2:56 pm Purchase | 2024-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 13,063 0.700% | 11,436 (+702.89%) | Filing History |
| 2024-11-14 4:42 pm Purchase | 2024-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 15,001 0.830% | 13,823 (+1173.43%) | Filing History |
| 2024-11-14 4:40 pm Sale | 2024-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group L.P. | 0 0.000% | -1,830 (Position Closed) | Filing History |
| 2024-10-16 09:01 am Unchanged | 2024-09-30 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management, LP | 17,399 1.340% | 0 (Unchanged) | Filing History |
| 2024-06-20 4:01 pm Purchase | 2024-06-12 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | L1 Capital Global Opportunities Master Fund, Ltd. | 4,322 9.990% | 4,322 (New Position) | Filing History |
| 2024-02-14 4:00 pm Sale | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 0 0.000% | -225 (Position Closed) | Filing History |
| 2024-02-14 3:56 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 1,178 6.710% | 1,178 (New Position) | Filing History |
| 2024-02-14 1:55 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group L.P. | 1,830 9.990% | 1,830 (New Position) | Filing History |
| 2024-01-11 4:53 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management, LP | 17,399 9.990% | 17,399 (New Position) | Filing History |
| 2024-01-03 4:23 pm Purchase | 2023-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 1,627 11.000% | 1,627 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 225 7.400% | 11 (+5.14%) | Filing History |
| 2022-12-27 5:05 pm Purchase | 2022-12-16 | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 214 7.400% | 214 (New Position) | Filing History |